The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ATAI Life Sciences N.V shares valued at $198,408 were purchased by SAHIL KIRPEKAR on Jun 04 ’25. At $2.48 per share, SAHIL KIRPEKAR acquired 80,000 shares.
Also, Kirpekar Sahil sold 48,563 shares, netting a total of over 65,560 in proceeds. Following the sale of shares at $1.35 each, the insider now holds 115,636 shares.
Before that, Craig Kevin James had sold 11,563 shares from its account. In a trade valued at $15,610, the Chief Medical Officer traded ATAI Life Sciences N.V shares for $1.35 each. Upon closing the transaction, the insider’s holdings decreased to 11,563 shares, worth approximately $18561.4.
As published in a research note from H.C. Wainwright on November 18, 2024, ATAI Life Sciences N.V [ATAI] has been retained to a Buy and the price target has been revised to $10. Analysts at Maxim Group upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early April. As of November 01, 2022, Loop Capital has initiated its “Buy” rating for ATAI. Earlier on November 30, 2021, Maxim Group initiated its rating. Their recommendation was “a Buy” for ATAI stock.
Analyzing ATAI Stock Performance
On last trading session,, ATAI Life Sciences N.V [NASDAQ: ATAI] rose 4.27% to $2.2. The stock’s lowest price that day was $2.04, but it reached a high of $2.2 in the same session. During the last five days, there has been a drop of approximately -0.90%. Over the course of the year, ATAI Life Sciences N.V shares have jumped approximately 64.18%. Shares of the company reached a 52-week high of $2.64 on 06/02/25 and a 52-week low of $1.15 on 04/09/25.
Support And Resistance Levels for ATAI Life Sciences N.V (ATAI)
According to the 24-hour chart, there is a support level at 2.09, which, if violated, would cause prices to drop to 1.99. In the upper region, resistance lies at 2.25. The next price resistance is at 2.31. RSI (Relative Strength Index) is 52.71 on the 14-day chart, showing neutral technical sentiment.
Is ATAI Life Sciences N.V subject to short interest?
Stocks of ATAI Life Sciences N.V saw a sharp steep in short interest on 2025-05-30 dropping by -0.65 million shares to 11.55 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 12.19 million shares. A decline of -5.59% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.41 of the overall float, the days-to-cover ratio (short ratio) decline to 5.41.
Which companies own the most shares of ATAI Life Sciences N.V (ATAI)?
In terms of ATAI Life Sciences N.V share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, up nearly 136.97% from the previous closing price of $2.11. Analysts anticipate ATAI Life Sciences N.V stock to reach 5 by 2025, with the lowest price target being 5. In spite of this, 1 analysts ranked ATAI Life Sciences N.V stock as Buy at the end of 2025. On November 11, 2021, ROTH Capital assigned a price target of “a Buy” to the stock and initiated coverage with a $32.
